Thomas C. Chen
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$2.3MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $2.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 23, 2025 | NIH | STTR Phase II Developing a Clinically Relevant Radiosensitizer for Temozolomide-resistant Gliomas | $1.0M | NEONC TECHNOLOGIES INC |
| Aug 6, 2025 | NIH | STTR Phase I Development of NEO212, A Novel Oral Drug for the Treatment of Acute Myeloid Leukemia | $400K | NEONC TECHNOLOGIES INC |
| Mar 25, 2020 | NIH | STTR Phase I Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas | $336K | NEONC TECHNOLOGIES INC |
| Aug 6, 2019 | NIH | STTR Phase I Innovative Nose-to-Brain Anticancer Drug Transport Facilitated by NEO100 | $1K | NEONC TECHNOLOGIES INC |
| Mar 23, 2018 | NIH | STTR Phase I Innovative Nose-to-Brain Anticancer Drug Transport Facilitated by NEO100 | $300K | NEONC TECHNOLOGIES INC |
| Jun 20, 2016 | NIH | STTR Phase I Temozolomide Perillyl Alcohol Conjugate as Treatment for Recurrent Malignant Brain tumors | $300K | NEONC TECHNOLOGIES INC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#832
Awards as PI#315
Patents#273
Companies
- NEONC TECHNOLOGIES INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.